Greystone Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-16,452
Closed -$790K 89
2021
Q3
$790K Sell
16,452
-9,116
-36% -$441K 0.23% 76
2021
Q2
$1.07M Buy
25,568
+1,110
+5% +$43K 0.27% 69
2021
Q1
$937K Buy
+24,458
New +$871K 0.24% 68

Other funds holding NVO

Greystone Financial Group's NVO Position: Q4 2021 in Review

Greystone Financial Group sold out of Novo Nordisk (NVO) in Q4 2021, closing a stake of 16,452 shares — an estimated $790K sold.

Greystone Financial Group first reported a position in NVO in Q1 2021 and held it in 3 quarters. The position peaked at $1.07M in Q2 2021. 886 funds tracked by Wall St. Rank hold NVO as of Q4 2021.

  • Greystone Financial Group reported no remaining Novo Nordisk position as of Q4 2021 after selling out during the quarter.
  • Greystone Financial Group sold 16,452 Novo Nordisk shares in Q4 2021, an estimated $790K.
  • Greystone Financial Group first reported a position in Novo Nordisk in Q1 2021 and held it in 3 quarters.
  • Greystone Financial Group's Novo Nordisk position peaked at $1.07M in Q2 2021.
  • 886 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2021.

Based on Greystone Financial Group's 13F filing for Q4 2021, filed 1 Feb 2022.